A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

October 3, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
Heart FailureChronic Kidney Diseases
Interventions
DRUG

Sodium Zirconium Cyclosilicate

Use of sodium zirconium cyclosilicate to optimize RAASi therapy, through up-titration of ACEi, ARB, ARNI or MRA therapy according to clinical guidelines

DRUG

Standard of care treatment (RAASi therapy)

Standard of care treatment (RAASi therapy) without use of sodium zirconium cyclosilicate

Trial Locations (6)

14004

NOT_YET_RECRUITING

Hospital Universitario Reina Sofía, Córdoba

28914

NOT_YET_RECRUITING

Hospital Universitario Severo Ochoa, Leganés

28922

NOT_YET_RECRUITING

Hospital Universitario Fundación Alcorcón, Alcorcón

46010

RECRUITING

Hospital Clínico Universitario de Valencia, Valencia

02006

RECRUITING

Hospital Universitario Nuestra Señora del Perpétuo Socorro, Albacete

09006

RECRUITING

Hospital Universitario de Burgos, Burgos

All Listed Sponsors
lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER